+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID07291206

Study of T Cell Responses to Arbovirus Infections Using ELISpot Tests in Adults

Led by Fondazione IRCCS Policlinico San Matteo di Pavia · Updated on 2026-03-04

500

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

This research focuses on arboviruses, a group of RNA viruses spread by insects like mosquitoes, ticks, and sandflies, which can infect humans and cause serious diseases. In Italy, certain arboviruses are common, while others are monitored closely because travel and climate change may increase their spread. The study aims to examine immune responses in patients infected with these viruses to improve diagnosis and control outbreaks. The study evaluates immunological tests, specifically the ELISpot assay, to monitor T-cell responses against arboviruses. These tests are studied alongside traditional molecular and serological methods, aiming to improve diagnosis since molecular tests have limited detection windows and serological tests can cross-react between viruses. The study uses these immunological assays to better detect and understand arbovirus infections. Participants suspected of having arbovirus infections will undergo immunological testing to assess their T-cell response over up to one year. Researchers will measure how well these T-cell based assays perform in detecting arbovirus infections. The study involves collecting samples for testing and monitoring immune responses, helping to identify patients at risk and improve disease surveillance and control. Participation includes informed consent and regular follow-up evaluations.

CONDITIONS

Brief Title

ARBOspot: Characterization of Arbovirus Specific T Cell Response in Patients by Using Enzyme Linked Immunospot (ELISpot) Assays

Research Team

B

Baldanti

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here